|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 199.66 USD | -2.06% |
|
-8.97% | -17.46% |
| 10:40am | Citigroup Downgrades ResMed to Neutral From Buy, Adjusts Price Target to $235 From $270 | MT |
| 07:48am | Citi Downgrades ResMed to Neutral From Buy; Price Target is AU$34 | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Bearish |
| Resistance | 219.75 | 230.7 | 233.52 |
| Spread/Res. | -9.53% | -13.83% | -14.87% |
| Spread/Supp. | +0.95% | +8.74% | +5.39% |
| Support | 196.94 | 182.82 | 188.63 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RMD Stock
- Charts ResMed, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
